1.
Strober B, Krueger J, Magnolo N, Vender R, Toth D, Thaci D, Wang M, Cioffi C, Madden C, Warren R. Bimekizumab versus Ustekinumab Efficacy Across Subgroups of Patients with Moderate to Severe Plaque Psoriasis: Results from the Multicenter, Randomized, Double-Blinded Phase 3 BE VIVID Trial. J of Skin [Internet]. 2021Jan.1 [cited 2024Sep.20];5(1):s16. Available from: https://dermsquared.com/skin/article/view/1169